Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06640894Not ApplicableRecruiting

Power2Walk: The Impact of Functional Power Training on Participation and Activity in Children With Cerebral Palsy.

Role: collaborator

NCT06082492Not ApplicableRecruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

Role: collaborator

NCT02947503Phase 3Recruiting

Pregnancy Outcomes: Effects of Metformin Study (POEM Study)

Role: collaborator

All 3 trials loaded